ACCURAY INC

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for tumor treatment globally. The company operates in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. Accuray offers the CyberKnife platform, a robotic system for stereotactic radiosurgery and stereotactic body radiation therapy. This system treats primary and metastatic tumors outside the brain, including those on or near the spine, and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, which includes the Radixact System. This system integrates radiation treatment planning, delivery, and data management, allowing clinicians to deliver ultra-precise treatments to approximately 50 patients per day. Other offerings include the iDMS data management system and the Accuray precision treatment planning system, both fully integrated treatment planning and data management systems. Beyond systems, Accuray provides post-contract customer support, installation, training, and other professional services. The company markets its products directly to hospitals and stand-alone treatment facilities through its sales organization. In the United States, it also sells through sales agents and group purchasing organizations, while internationally, it sells directly and through distributors and sales agents. Accuray Incorporated was established in 1990 and is headquartered in Madison, Wisconsin.